https://doi.org/10.31288/oftalmolzh201554651

Stabilizing quercetin and lipoate effect on enzymatic antioxidant system (glutathione peroxidase and glutathione reductase) in the retina during experimental diabetes treatment

O. A. Moroz, Ph.D. in Medical Sciences

A. Novak Transcarpathian Regional Clinical Hospital

Uzhgorod (Ukraine)

E-mail: moroz.oleg@gmail.com

Introduction. The thesis actuality consists in studying the quercetin and lipoate effect during experimental diabetes treatment.

Objective. To study the quercetin and lipoate effect on the antioxidant system enzymes, particularly, glutathione peroxidase and glutathione reductase during experimental diabetes.

Material and methods. Researches were conducted on white rats. Experimental animals were divided into four groups: the first one – control group (14 rats); the second one – experimental group (14 rats), animals with developing diabetes, without drug administration; the third one – experimental group (12 rats), animals with developing diabetes and lipoic acid administration; the fourth one – experimental group (15 rats), animals with developing diabetes and quercetin administration. The activity of glutathione peroxidase and glutathione reductase was determined in homogenates of retinas and blood plasma.

Results. The usage of thiol preparations and bioflavanoid considerably contributes to the stabilization of hydroperoxide neutralization processes in the retina in conditions of experimental diabetes. It is also required to specify that the effect of a thiol preparation – lipoic acid was more expressed as compared with quercetin.

Conclusion. The effect of lipoic acid and quercetin preparations during the experimental diabetes (2 & 6 months) considerably allows avoiding the inhibition of antioxidant system enzymes in animal retina. It is confirmed by the increase of the activity of glutathione peroxidase in the retina when using lipoate by 65.0% (in 2 months) and by 74.3% (in 6 months), and glutathione reductase - by 26.7% (in 2 months) and by 34.4% (in 6 months) for the group of untreated animals. The quercetin injection increases the activity of glutathione peroxidase by 60.6% (in 2 months) and by 65.9% after six months, and glutathione reductase by 20.4 and 29.8% correspondingly. The most expressed effect for reducing the degree of damage of antioxidant system enzymes is specific for lipoic acid.

Key words: streptozotocin-induced diabetes, retina, glutathione peroxidase, glutathione reductase, quercetin, lipoate, experiment

References

1. Gogina IF, Andriu LV, Ogranovich OE. [Diabetic angio-, retino-, neuropathy: patogenesis, clinic, treatment], Lviv: Liga press; 2000. 186 p. In Ukrainian.

2. Evgrafov VYu. [Diabetic retinopathy: patogenesis, diagnosis, treatment: syn. of thes. ... of M.D.]. М. 1996; 47 p. In Russian.

3. Efimov А, Skorobonskaya N, Zueva N. [Diabetic neuropathy]. Liky Ukrainy; 2005; 3: 21-25. In Russian.

4. Kravchuk EA. [The role of free radical oxidation in pathogenesis of eye diseases]. Vestnik oftalmologii. 2004; 5: 48-51. In Russian.

5. Kryzhanovskaya TV. [Nosotropic rehabilitation aspects of diabetic retinopathy patients]. Mater. of 2-nd Inter. Conf. “Modern Aspects of Cardioendocrinopathy of Ocular Organ”. K. 2005: 73-74. In Russian.

6. Leus NF. [Metabolic development mechanisms and pharmacotherapy aspects of diabetic retinopathy]. Oftalmol Zh. 2003; 5: 75-80. Russian.

7. Nasledov A. [SPSS computer data analysis in psychology and social sciences]. Spb.: Peter; 2005. 416 p. In Russian.

8. Nedzvetskaya OV. [Modern trends in diabetic retinopathy treatment]. Intern. Med. J., 2000; 3: 56-58. In Russian.

9. Olejnik ТV. [The effect of vitamin-coenzyme complexes on antioxidant enzymes retina system during experimental diabetes]. Oftalmol Zh.. 2007; 6.: 58-61. In Russian.

10. Pavlyuchenko KP, Mogilevsky SYu, Chujko AL. [The state of antioxidant enzymes system in the retina during experimental diabetes and application of vatamin В6]. J. Oftalmol Zh. 2011; 3: 73-78. In Russian.
Crossref

11. Pasechnikova NV, Naumenko VA, Zborovskaya AV. [Blood-retinal barrier state during diabetic retinopathy as per fluorometry data]. Oftalmol Zh. 2008; 5: 4-7. In Russian.

12. Pasechnikova NV. [Laser treatment during ocular fundus pathology]. Pasechnikova NV. Kyiv: Research and production association “Naukova dumka” publishing house of NAS of Ukraine”; 2007. 201 p. In Russian.

13. Sidorova MV. [Diabetic retinopathy. Pathogenesis, clinic, treatment]. K.: SMP “AVERS”; 2006. 156 p. In Russian.

14. Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am. J. Ophthalmol. 2001; 32: 760-776.
Crossref

15. Barber A. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog. In Neuro-Psychopharm. Biol. Psych. 2003; 27: 283 – 290.
Crossref

16. Bergmeyer HU. Methoden der enzymatischen Analyse. Berlin. 1986; 2220 p.

17. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813-820.
Crossref

18. Fong DS, Aiello LP, Ferris FL, Klein RK. Diabetic retinopathy. Ophthalmol. 2004; 27: 2540-2553.
Crossref

19. Jandric-Balen M, Bozikov V, Bistrovic D. Antioxidant enzymes activity in patients with peripheral vascular disease, with and without presence of diabetes mellitus. Coll. Antropol. 2003; 27: 735-743.

20. Halliwell B. The role of oxygen radicals in human disease with particular reference to the vascular system. Haemostasis. 1993; 23: 118-126.

21. Lang GE: Pharmacological treatment of diabetic retinopathy. Ophthalmologica. 2007; 221: 112-117.

22. Muchova J, Liptakova A, Orzaghova Z. Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus. Diabet. Med. 1999; 16: 74-78.

23. Speicher MA, Danis RP, Criswell M. Pharmacologic therapy for diabetic retinopathy. Expert Opion Emerg Drugs. 2003; 8 (1): 239-250.

24. Ulusu NN, Sahilli M, Avci A: Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant argans: effects of stobadine and vitamin E. Neurochem. Res. 2003; 28 (6): 815 – 823.

25. Winkler R, Moser M: Alterations of antioxidant tissue defense enzymes and related metabolic parameters in streptozotocin-diabetic rats-effects of iodine treatment. Wien Klin. Wochenschr. 1992; 104: 409-413